<VariationArchive VariationID="928542" VariationName="NM_014625.4(NPHS2):c.419del (p.Gly140fs)" VariationType="Deletion" Accession="VCV000928542" Version="12" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-06-17" DateCreated="2020-06-22" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="916806" VariationID="928542">
      <GeneList>
        <Gene Symbol="NPHS2" FullName="NPHS2 stomatin family member, podocin" GeneID="7827" HGNC_ID="HGNC:13394" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q25.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="179550539" stop="179575948" display_start="179550539" display_stop="179575948" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="179519673" stop="179545083" display_start="179519673" display_stop="179545083" Strand="-" />
          </Location>
          <OMIM>604766</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014625.4(NPHS2):c.419del (p.Gly140fs)</Name>
      <CanonicalSPDI>NC_000001.11:179561320:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q25.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="179561321" stop="179561321" display_start="179561321" display_stop="179561321" variantLength="1" positionVCF="179561320" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="179530456" stop="179530456" display_start="179530456" display_stop="179530456" variantLength="1" positionVCF="179530455" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G140fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.179530458del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.179530458del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.179561323del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.179561323del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007535.1" sequenceAccession="NG_007535" sequenceVersion="1" change="g.19629del">
            <Expression>NG_007535.1:g.19629del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001297575.2" sequenceAccession="NM_001297575" sequenceVersion="2" change="c.419del">
            <Expression>NM_001297575.2:c.419del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001284504.1" sequenceAccession="NP_001284504" sequenceVersion="1" change="p.Gly140fs">
            <Expression>NP_001284504.1:p.Gly140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014625.4" sequenceAccession="NM_014625" sequenceVersion="4" change="c.419del" MANESelect="true">
            <Expression>NM_014625.4:c.419del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055440.1" sequenceAccession="NP_055440" sequenceVersion="1" change="p.Gly140fs">
            <Expression>NP_055440.1:p.Gly140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_887" sequenceAccession="LRG_887">
            <Expression>LRG_887:g.19629del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014625.3" sequenceAccession="NM_014625" sequenceVersion="3" change="c.419delG">
            <Expression>NM_014625.3:c.419delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604766.0004" DB="OMIM" />
        <XRef Type="rs" ID="749779208" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014625.4(NPHS2):c.419del (p.Gly140fs) AND Nephrotic syndrome, type 2" Accession="RCV001192595" Version="6">
        <ClassifiedConditionList TraitSetID="1496">
          <ClassifiedCondition DB="MedGen" ID="C1868672">Nephrotic syndrome, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014625.4(NPHS2):c.419del (p.Gly140fs) AND not provided" Accession="RCV001388077" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014625.4(NPHS2):c.419del (p.Gly140fs) AND Steroid-resistant nephrotic syndrome" Accession="RCV001833740" Version="1">
        <ClassifiedConditionList TraitSetID="33396">
          <ClassifiedCondition DB="MedGen" ID="C0403397">Steroid-resistant nephrotic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-06-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014625.4(NPHS2):c.419del (p.Gly140fs) AND Nephrotic syndrome" Accession="RCV001849477" Version="1">
        <ClassifiedConditionList TraitSetID="16911">
          <ClassifiedCondition DB="MedGen" ID="C0027726">Nephrotic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-11-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014625.4(NPHS2):c.419del (p.Gly140fs) AND NPHS2-related disorder" Accession="RCV003393872" Version="4">
        <ClassifiedConditionList TraitSetID="89719">
          <ClassifiedCondition>NPHS2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-04" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2020-06-22" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10742096</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11729243</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11805166</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14701729</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15253708</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20507940</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23595123</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28385484</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29127259</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16911" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="21310" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephrotic syndrome</ElementValue>
                <XRef ID="HP:0000100" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005377" DB="MONDO" />
                <XRef ID="52254009" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0027726" DB="MedGen" />
              <XRef ID="MONDO:0005377" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000100" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000801" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004718" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008638" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008727" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1496" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5624" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nephrotic syndrome, steroid-resistant, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephrotic syndrome, type 2</ElementValue>
                <XRef ID="MONDO:0010974" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary nephrotic syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRN1</ElementValue>
                <XRef Type="MIM" ID="600995" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NPHS2</ElementValue>
                <XRef Type="MIM" ID="600995" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15326" />
                <XRef ID="15326" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34436835</ID>
                <ID Source="BookShelf">NBK573219</ID>
              </Citation>
              <XRef ID="656" DB="Orphanet" />
              <XRef ID="C1868672" DB="MedGen" />
              <XRef ID="MONDO:0010974" DB="MONDO" />
              <XRef Type="MIM" ID="600995" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33396" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="30468" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Steroid-resistant nephrotic syndrome</ElementValue>
                <XRef ID="HP:0012588" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0044765" DB="MONDO" />
                <XRef ID="236381000" DB="SNOMED CT" />
              </Name>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34436835</ID>
                <ID Source="BookShelf">NBK573219</ID>
              </Citation>
              <XRef ID="C0403397" DB="MedGen" />
              <XRef ID="MONDO:0044765" DB="MONDO" />
              <XRef Type="primary" ID="HP:0012588" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89719" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71100" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">NPHS2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NPHS2-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2669151" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_014625.2:c.419del|MedGen:C3496337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001360833" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20507940</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11805166</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11729243</ID>
          </Citation>
          <Comment>Variant summary: NPHS2 c.419delG (p.Gly140AspfsX41) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 8e-06 in 251538 control chromosomes. c.419delG has been reported in the literature in multiple individuals affected with Nephrotic Syndrome (Caridi_2001, Karle_2002, Machuca_2010). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014625.2:c.419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Idiopathic nephrotic syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3496337" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4082780" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_014625.4:c.419del|Steroid-resistant nephrotic syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002090092" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014625.4:c.419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Steroid-resistant nephrotic syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4124330" SubmissionDate="2022-03-21" DateLastUpdated="2022-03-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_001297575.2:c.419del|HPO:0000100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002106957" DateUpdated="2022-03-28" DateCreated="2022-03-28" Type="SCV" Version="1" SubmitterName="Yale Center for Mendelian Genomics, Yale University" OrgID="506150" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29127259</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001297575.2:c.419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0000100" />
          </Trait>
        </TraitSet>
        <StudyName>Yale Center for Mendelian Genomics</StudyName>
        <StudyDescription>The Yale Center for Mendelian Genomics is one of the national centers created by the NIH to study the genetics of rare inherited diseases.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB11200512</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25876" SubmissionDate="2022-03-04" DateLastUpdated="2022-03-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604766.0004_NEPHROTIC SYNDROME, TYPE 2" title="NPHS2, 1-BP DEL, 419G_NEPHROTIC SYNDROME, TYPE 2" />
        <ClinVarAccession Accession="SCV000025876" DateUpdated="2022-03-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with steroid-resistant nephrotic syndrome (600995), Boute et al. (2000) identified a frameshift mutation, a deletion of a G at nucleotide 419 (419delG) in exon 3 of the NPHS2 gene. This mutation was found in compound heterozygosity with another frameshift mutation (see 604766.0003).</Attribute>
              <Citation>
                <ID Source="PubMed">10742096</ID>
              </Citation>
              <XRef DB="OMIM" ID="600995" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Caridi et al. (2001) found a homozygous 419delG mutation in 3 Italian patients with sporadic steroid-resistant nephrotic syndrome with focal segmental glomerulosclerosis. Onset occurred before age 4 years and all progressed to renal failure necessitating transplantation. Haplotype analysis indicated a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">11729243</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHS2" />
          </GeneList>
          <Name>NPHS2, 1-BP DEL, 419G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 419G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604766.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEPHROTIC SYNDROME, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5038442" SubmissionDate="2022-10-01" DateLastUpdated="2022-10-08" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="NM_014625.4:c.419del|OMIM:600995" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002577536" DateUpdated="2022-10-08" DateCreated="2022-10-08" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PS4, PM2, PP3, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014625.4:c.419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600995" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12117196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7577099" SubmissionDate="2023-10-18" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="NM_014625.4:c.419del|OMIM:600995" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004049287" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014625.4:c.419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600995" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13910671</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7697966" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="3545744|NPHS2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004121580" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NPHS2 c.419delG variant is predicted to result in a frameshift and premature protein termination (p.Gly140Aspfs*41). This variant has been reported in the homozygous and compound heterozygous state in many individuals with steroid resistant nephrotic syndrome (Boute et al 2000. PubMed ID: 10742096; Supp. Table 9 in Warejko JK et al 2017. PubMed ID: 29127259; Karle SM et al 2002. PubMed ID: 11805166; Weber S et al 2004. PubMed ID: 15253708). This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-179530455-TC-T). Frameshift variants in NPHS2 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014625.3:c.419delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NPHS2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3114585" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4821894|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001588922" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10742096</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14701729</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15253708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23595123</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10742096</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28385484</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly140Aspfs*41) in the NPHS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS2 are known to be pathogenic (PMID: 10742096, 14701729, 15253708, 23595123). This variant is present in population databases (rs749779208, gnomAD 0.002%). This premature translational stop signal has been observed in individuals with nephrotic syndrome (PMID: 10742096, 28385484). ClinVar contains an entry for this variant (Variation ID: 928542). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.179530456del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7847041" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_014625.4:c.419del|OMIM:600995" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004191526" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014625.4:c.419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600995" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2669151" TraitType="Disease" MappingType="Name" MappingValue="Idiopathic nephrotic syndrome" MappingRef="Preferred">
        <MedGen CUI="C3496337" Name="Idiopathic nephrotic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7577099" TraitType="Disease" MappingType="XRef" MappingValue="600995" MappingRef="OMIM">
        <MedGen CUI="C1868672" Name="Nephrotic syndrome, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25876" TraitType="Disease" MappingType="Name" MappingValue="NEPHROTIC SYNDROME, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1868672" Name="Nephrotic syndrome, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7697966" TraitType="Disease" MappingType="Name" MappingValue="NPHS2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NPHS2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4124330" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000100" MappingRef="HP">
        <MedGen CUI="C0027726" Name="Nephrotic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3114585" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7847041" TraitType="Disease" MappingType="XRef" MappingValue="600995" MappingRef="OMIM">
        <MedGen CUI="C1868672" Name="Nephrotic syndrome, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4082780" TraitType="Finding" MappingType="Name" MappingValue="Steroid-resistant nephrotic syndrome" MappingRef="Preferred">
        <MedGen CUI="C0403397" Name="Steroid-resistant nephrotic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5038442" TraitType="Disease" MappingType="XRef" MappingValue="600995" MappingRef="OMIM">
        <MedGen CUI="C1868672" Name="Nephrotic syndrome, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

